Branaplam (LMI070)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Branaplam (LMI070), covering 2024-11-04 to 2024-11-04. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Range Finding Study With Open-Label Extension to Evaluate the Safety of Oral LMI070/Branaplam in Early Manifest Huntington's Disease [Phase 2]